ProfileGDS4132 / 209400_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 41% 48% 36% 42% 37% 38% 41% 38% 35% 31% 30% 39% 44% 34% 25% 33% 37% 33% 34% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10187.213534
GSM201543Muscle PCOS pioglitazone 12199.451641
GSM201544Muscle PCOS pioglitazone 161130.38248
GSM201545Muscle PCOS pioglitazone 201100.77336
GSM201829Muscle PCOS pioglitazone 231117.5942
GSM201830Muscle PCOS pioglitazon 25197.18537
GSM201831Muscle PCOS pioglitazone 27196.275938
GSM201832Muscle PCOS pioglitazone 31104.32641
GSM201833Muscle PCOS pioglitazone 4192.168138
GSM201834Muscle PCOS pioglitazone 8185.977335
GSM201835Muscle PCOS after pioglitazone 10262.361631
GSM201836Muscle PCOS after pioglitazone 12261.78530
GSM201837Muscle PCOS after pioglitazone 16285.253339
GSM201838Muscle PCOS after pioglitazone 202103.69244
GSM201839Muscle PCOS after pioglitazone 23278.364234
GSM201840Muscle PCOS after pioglitazone 25257.167325
GSM201841Muscle PCOS after pioglitazone 27268.29433
GSM201842Muscle PCOS after pioglitazone 3275.978937
GSM201843Muscle PCOS after pioglitazone 4280.75333
GSM201844Muscle PCOS after pioglitazone 8280.241234